{"title":"ANXA1 facilitates myeloid-derived suppressor cell infiltration in the non-small cell lung cancer immunomicroenvironment via the STING/NF-κB/CXCL5/CXCR2 signaling axis to enhance tumor progression.","authors":"Xinyue Liu, Xiangtian Xiao, Yanqi Feng, Yiming Li, Shuxi Yao, Yuelin Han, Shu Xia","doi":"10.1016/j.bbadis.2025.167965","DOIUrl":"https://doi.org/10.1016/j.bbadis.2025.167965","url":null,"abstract":"<p><p>The infiltration of immune cells within the tumor microenvironment is a crucial determinant of the therapeutic efficacy of cancer immunotherapy. In non-small cell lung cancer (NSCLC), elucidating the regulatory mechanisms that govern the immune microenvironment is of substantial clinical importance. This study identifies Annexin A1 (ANXA1) as a key mediator in promoting the establishment of an immunosuppressive microenvironment driven by tumor cells. Clinical findings demonstrate that increased ANXA1 expression in NSCLC is highly correlated with worse prognosis and reduced effectiveness of immunotherapy. Complementary in vivo experiments further demonstrate that ANXA1 facilitates subcutaneous tumor progression and enhances the recruitment of myeloid-derived suppressor cells (MDSCs), thus fostering an immunosuppressive tumor microenvironment. Mechanistically, ANXA1 modulates the methylation status of UHRF1 (Ubiquitin-like plant homeodomain and RING finger domain-containing protein 1), disrupting DNA damage repair processes and leading to the accumulation of cytosolic double-stranded DNA (dsDNA), which triggers the activation of the STING/NF-κB/CXCL5 signaling axis. CXCL5 binds to its receptor CXCR2 on MDSCs, thereby promoting their recruitment. Importantly, inhibition of CXCR2 effectively reverses ANXA1-mediated MDSCs infiltration. These results elucidate the essential function of ANXA1 in modulating the recruitment of MDSCs within the immune environment of NSCLC, establishing ANXA1 as a significant therapeutic target for the advancement of innovative immunotherapeutic approaches.</p>","PeriodicalId":93896,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":" ","pages":"167965"},"PeriodicalIF":0.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144568212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yan Huo, Zhe Zhang, Suzhen Dong, Yijie Du, Mingliang Ma
{"title":"Advances in clinical studies of peptide drugs in stroke disease.","authors":"Yan Huo, Zhe Zhang, Suzhen Dong, Yijie Du, Mingliang Ma","doi":"10.1016/j.bbadis.2025.167970","DOIUrl":"https://doi.org/10.1016/j.bbadis.2025.167970","url":null,"abstract":"<p><p>Stroke remains a leading cause of death and disability globally, with limited treatment options currently available. Fortunately, peptide drugs have emerged as promising candidates for treating central nervous system disorders, including stroke. They offer high specificity, low toxicity, and efficient blood-brain barrier penetration, demonstrating significant therapeutic potential. This review systematically introduces several promising peptide drugs, analyzing their mechanisms, therapeutic efficacy in clinical trials, and potential applications. It also addresses critical challenges in peptide drug development for stroke therapy, such as optimizing dosing strategies, enhancing stability, and improving delivery systems. The analysis of current clinical evidence suggests that peptide-based therapeutics represent a promising frontier in stroke treatment, potentially offering new therapeutic options for patients. This comprehensive review not only highlights the current status of peptide drug development but also provides insights into future directions for advancing stroke therapy.</p>","PeriodicalId":93896,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":" ","pages":"167970"},"PeriodicalIF":0.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Special issue - Mitochondria in aging, cancer and cell death.","authors":"Ana M Urbano, Paulo J Oliveira","doi":"10.1016/j.bbadis.2025.167954","DOIUrl":"https://doi.org/10.1016/j.bbadis.2025.167954","url":null,"abstract":"","PeriodicalId":93896,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":" ","pages":"167954"},"PeriodicalIF":0.0,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"High fluid shear stress induces Hippo/YAP pathway in articular cartilage superficial layer cells: A potential mechanistic link to osteoarthritis.","authors":"Haitao Li, Yuxuan Ou, Lifu Chen, Yong Li, Wei Wang, Jian Wang","doi":"10.1016/j.bbadis.2025.167939","DOIUrl":"https://doi.org/10.1016/j.bbadis.2025.167939","url":null,"abstract":"<p><p>Abnormal mechanical loading, which can lead to articular cartilage damage, is a significant contributor to the onset of osteoarthritis (OA). Articular cartilage superficial layer cells are among the first cells to respond to changes in the mechanical environment and are highly sensitive to mechanical stimuli. This study aimed to investigate the effects of high fluid shear stress on the articular cartilage superficial layer cells and the underlying mechanisms. We found that high fluid shear stress of 20 dyne/cm<sup>2</sup> induces inflammation and promotes catabolic processes in these cells. Short-term high fluid shear stress has a protective effect, but its efficacy varies with time. YAP plays a crucial role in mediating the effects of high fluid shear stress and may represent a potential therapeutic target for early-stage osteoarthritis. The study also established osteoarthritis models using anterior cruciate ligament transection (ACLT) or injection of sodium iodoacetate (MIA) to further confirm the findings.</p>","PeriodicalId":93896,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":" ","pages":"167939"},"PeriodicalIF":0.0,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An epigenetic perspective of viral diseases, including cancer and autophagy.","authors":"Samir Kumar Patra","doi":"10.1016/j.bbadis.2025.167664","DOIUrl":"10.1016/j.bbadis.2025.167664","url":null,"abstract":"","PeriodicalId":93896,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":" ","pages":"167664"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hengxuan Cai, Guanpeng Ma, Zhenming Zhang, Guojie Liu, Rongzhe Lu, Yige Liu, Jiaxin Wang, Shanjie Wang, Song Sun, Mingyan E, Zhaoying Li, Shaohong Fang, Bo Yu
{"title":"A potential early-atheroprotective target: Irgm1 mediates lymphangiogenesis through LEC autophagy by Tfeb translocation.","authors":"Hengxuan Cai, Guanpeng Ma, Zhenming Zhang, Guojie Liu, Rongzhe Lu, Yige Liu, Jiaxin Wang, Shanjie Wang, Song Sun, Mingyan E, Zhaoying Li, Shaohong Fang, Bo Yu","doi":"10.1016/j.bbadis.2024.167238","DOIUrl":"10.1016/j.bbadis.2024.167238","url":null,"abstract":"<p><p>Lymphatic dysfunction is a pivotal pathological mechanism underlying the development of early atherosclerotic plaques. Potential targets of lymphatic function must be identified to realize the early prevention and treatment of atherosclerosis (AS). The immunity-related GTPase Irgm1 is involved in orchestrating cellular autophagy and apoptosis. However, the effect of Irgm1 on early AS progression, particularly through alterations in lymphatic function, remains unclear. In this study, we confirmed the protective effect of lymphangiogenesis on early-AS in vivo. Subsequently, an in vivo model of early AS mice with Irgm1 knockdown shows that Irgm1 reduces early atherosclerotic plaque burden by promoting lymphangiogenesis. Given that lymphatic endothelial cell (LEC) autophagy significantly contributes to lymphangiogenesis, Irgm1 may enhance lymphatic circulation by promoting LEC autophagy. Moreover, Irgm1 orchestrates autophagy in LECs by inhibiting mTOR and facilitating nuclear translocation of Tfeb. Collectively, these processes lead to lymphangiogenesis. Thus, this study establishes a link between Irgm1 and early AS, thus revealing a novel mechanism by which Irgm1 exerts an early protective influence on AS within the context of lymphatic circulation. The insights gained from this study have the potential to revolutionize the approach and management of AS onset.</p>","PeriodicalId":93896,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":" ","pages":"167238"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140960797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}